Ovarian carcinoma of low malignant potential treated at the Jewish General Hospital, Montreal, between 1973 and 1997

Canadian Journal of Surgery

Volumn 42, Issue 4, 1999, Pages 253-257

  Hinke, Vera ^a,b   Martin, Markus C ^a,c  

^a MCGILL UNIVERSITY   (Canada)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL HYSTERECTOMY; ADULT; AGED; CANADA; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; CYSTADENOMA; FEMALE; GENERAL HOSPITAL; HUMAN; HUMAN TISSUE; OMENTOPLASTY; OVARIECTOMY; OVARY CARCINOMA; OVARY CYST; POSTOPERATIVE CARE; REVIEW; SALPINGOOOPHORECTOMY;

ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0032819763     PISSN: 0008428X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Taylor HC. Malignant and semimalignant tumors of the ovary. Surg Gynecol Obstet 1929;48:702.
2. Serov SF, Scully RE, Sobin LH. Histological typing of ovarian tumors. In: International histologic classification of tumors. vol 9. Geneva: World Health Organization; 1973. p. 37-8.
3. Julian CG, Woodruff JD. The biologic behavior of low grade papillary serous carcinoma of the ovary. Obstet Gynecol 1972;40:860-7.
4. Bostwick DG, Tazelaar HD, Ballon SC, Hendrickson MR, Kempson RL. Ovarian epithelial tumor of borderline malignancy: a clinical and pathologic study of 109 cases. Cancer 1986;58: 2052-65.
5. Russel P. Surface epithelial-stromal tumors of the ovary. In: Kurman RJ, editor. Blaustein's pathology of the female genital tract. 4th ed. New York: Springer Verlag; 1994. p. 705-7.
6. Kurman RJ, Trimble CL. The behavior of serous tumors of low malignant potential: Are they ever malignant? Int J Gynecol Pathol 1993;12:120-7.
7. Lawrence WD. The borderland between benign and malignant surface epithelial ovarian tumors. Current controversy over the nature and nomenclature of "borderline" ovarian tumors. Cancer 1995;76(10 Suppl):2138-42.
8. Barnhill DR, Kurmann RJ, Brady MF, Omura GA, Yordan E, Given FT, et al. Preliminary analysis of the behavior of stage I ovarian serous tumors of low malignant potential. A Gynecologic Oncology Group Study. J Clin Oncol 1995;13(11):2752-6.
9. Colgan TJ, Norris HJ. Ovarian epithelial tumors of low malignant potential: a review. Int J Gynecol Pathol 1983;1 (4):367-82.
10. Hacker NF, Moore JG. Essentials of obstetrics and gynecology. 2nd ed. Philadelphia: WB Saunders; 1992. p. 606.
11. Robinson WR, Curtin JP, Morrow CP. Operative staging and conservative surgery in the management of low malignant potential ovarian tumors. Int J Gynecol Cancer 1992;2:113-8.
12. Rice LW, Berkowitz RS, Mark SD, Yavner DL, Lage JM. Epithelial ovarian tumors of borderline malignancy. Gynecol Oncol 1990;39(2):195-8.
13. Massad LS Jr, Hunter VJ, Szpak CA, Clarke-Pearson DL, Creasman WT. Epithelial ovarian tumors of low malignant potential [review]. Obstet Gynecol 1991;78(6):1027-32.
14. Barnhill D, Heller P, Brzozowski P, Advani H, Gallup D, Park R. Epithelial ovarian carcinoma of low malignant potential. Obstet Gynecol 1986;65(1): 53-9.
15. Kliman L, Rome RM, Fortune DW. Low malignant potential tumors of the ovary: a study of 76 cases. Obstet Gynecol 1986;68(3):338-44.
16. Nation JG, Krepart GV. Ovarian carcinoma of low malignant potential: staging and treatment. Am J Obstet Gynecol 1986;154:290-3.
17. O'Quinn AG, Hannigan EV. Epithelial ovarian neoplasm of low malignant potential. Gynecol Oncol 1985;21:177-85.
18. Tasker M, Langley FA. The outlook for women with borderline epithelial tumours of the ovary. Br J Obstet Gynaecol 1985;92:969-73.
19. Hopkins MP, Marley GW. The second-look operation and surgical re-exploration in ovarian tumor of low malignant potential. Obstet Gynecol 1989;74:375-8.
20. Fort MG, Pierce VK, Saigo PE, Hoskins WJ, Lewis JL Jr. Evidence for efficacy of adjuvant therapy in epithelial ovarian tumors of low malignant potential. Gynecol Oncol 1989;32(3): 269-72.
21. Clarke-Pearson DL, Dawood MY. Green's gynecology. 4th ed. Boston: Little, Brown and Company; 1990. p. 538.
22. Wadler S, Yeap B, Vogl S, Carbone P. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results - Eastern Cooperative Oncology Group Study E2878. Cancer 1996;77(4):733-42.
23. Tazelaar HD, Bostwick DG, Ballon SC, Hendrikson MR, Kempson RL. Conservative treatment of borderline ovarian tumors. Obstet Gynecol 1985; 66(3):417-22.
24. Creasman WT, Park R, Norris H, Disaia PJ, Morrow CP, Hreshchyshyn MM. Stage 1 borderline ovarian tumors. Obstet Gynecol 1982;59(1):93-6.
25. Piura B, Dgani R, Blickstein I. Epithelial ovarian tumors of borderline malignancy: a study of 50 cases. Int J Gynecol Cancer 1992;2:189-97.
26. Lim-Tan SK, Lajigas HB, Scully RE. Ovarian cystectomy for serous borderline tumors: a follow-up study of 35 cases. Obstet Gynecol 1988;72:775-80.
27. Darai E, Teboul J, Walker F, Benifla JL, Memeux E, Gulielmina JN, et al. Epithelial ovarian carcinoma of low malignant potential. Eur J Obstet Gynecol Reprod Biol 1996;66(2):141-5.